Skip to main content

Biosyent Inc(RX-X)
TSX Venture

Today's Change
Delayed Last Update

Closing Bell: Biosyent Inc up on Thursday (RX)

Automated Summaries - The Globe and Mail - Thu Apr 11, 4:02PM CDT

Today during trading, Biosyent Inc stock opened at $8.60 and closed at $8.60. It traded at a low of $8.58 to a high of $8.60.

The price advanced 0.23% from the previous day's close of $8.58.

Today across North America, the TSX Composite closed -0.73% at 22199.13, the S&P 500 closed -0.95% at 5160.64, the Dow Jones Industrial Average closed -1.09% at 38461.51 and the Nasdaq Composite closed -0.84% at 16170.36.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

Trading volume was 3,260 on 10 total trades, while having an average volume of 11,678 in the last five days.

Trading across the entire TSX-V saw 2,898 price advancers against 2,320 declines and 129 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, the shares have boosted 18.62% in 52 weeks, while in 2024, they have decreased -6.72%.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $99.67 million on a float of 11,616 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Based on 1.00 analysts, Biosyent Inc gets an average recommendation of "Moderate Buy" according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..

More from The Globe